Literature DB >> 15596202

Experience in performing pyelolithotomy and pyeloplasty in children on day-surgery basis.

Mahmoud Mohamed1, Graham Hollins, Mohamed Eissa.   

Abstract

OBJECTIVES: To evaluate the success of implementing a day-surgery admission policy for pyelolithotomy and pyeloplasty in pediatric cases.
METHODS: A retrospective audit of the urology day-surgery unit records was performed for the period of January 1994 to December 1998. The data included the number of patients and their sex, type of procedures performed, the criteria for case selection, and reported complications that required readmission. The mean patient age was 2.6 years. The decision to perform these procedures on a day-surgery basis was taken after completing preoperative investigations and making the decision for surgery. Several criteria were developed to ensure the success of this application. The parents' understanding of the day surgery concept was the most important criterion. Pyeloplasties were performed using the Anderson-Hynes technique without stenting and were performed only for patients with an extrarenal pelvis. Pain control was delivered through wound infiltration with long-acting local anesthetic followed by oral non-narcotic analgesics. The immediate follow-up period was 4 to 5 weeks postoperatively, and long-term follow-up data were available for 2.5 to 3 years.
RESULTS: During the study period, 209 patients underwent surgery for pelviureteral junction obstruction repair and 305 underwent pyelolithotomy for renal stones. Of these children, 85% were discharged the same day, with no reported readmissions during the immediate or delayed follow-up period.
CONCLUSIONS: The results of this study have demonstrated that day surgery can be safely used for children requiring open renal surgical procedures that have more traditionally been performed on an inpatient basis. This has considerable resource implications at little cost in terms of patient morbidity.

Entities:  

Mesh:

Year:  2004        PMID: 15596202     DOI: 10.1016/j.urology.2004.08.065

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Postoperative outcome following pyeloplasty in children using miniflank incision and transanastomotic stent: a prospective observational study.

Authors:  Devendra K Gupta; Shilpa Sharma
Journal:  Pediatr Surg Int       Date:  2011-05       Impact factor: 1.827

2.  Impact of drainage technique on pediatric pyeloplasty: Comparative analysis of externalized uretero-pyelostomy versus double-J internal stents.

Authors:  Linda C Lee; Niki Kanaroglou; Joseph M Gleason; Joao L Pippi Salle; Darius J Bägli; Martin A Koyle; Armando J Lorenzo
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

3.  Perioperative analgesia strategies in fast-track pediatric surgery of the kidney and renal pelvis: lessons learned.

Authors:  Jens Dingemann; Joachim F Kuebler; Mathias Wolters; Mirja von Kampen; Wilhelm A Osthaus; Benno M Ure; Marc Reismann
Journal:  World J Urol       Date:  2009-06-30       Impact factor: 4.226

4.  Fast-track concepts in routine pediatric surgery: a prospective study in 436 infants and children.

Authors:  Marc Reismann; Jens Dingemann; Mathias Wolters; Birgit Laupichler; Robert Suempelmann; Benno M Ure
Journal:  Langenbecks Arch Surg       Date:  2008-12-03       Impact factor: 3.445

Review 5.  [Urolithiasis in children--rational diagnosis, therapy, and metaphylaxis].

Authors:  D Fahlenkamp; B Noack; S Lebentrau; H Belz
Journal:  Urologe A       Date:  2008-05       Impact factor: 0.639

6.  [Fast tracking in pediatric surgery].

Authors:  S Holland-Cunz; P Günther
Journal:  Chirurg       Date:  2009-08       Impact factor: 0.955

Review 7.  Guidelines on pediatric day surgery of the Italian Societies of Pediatric Surgery (SICP) and Pediatric Anesthesiology (SARNePI).

Authors:  Ugo de Luca; Giovanni Mangia; Simonetta Tesoro; Ascanio Martino; Maria Sammartino; Alessandro Calisti
Journal:  Ital J Pediatr       Date:  2018-03-12       Impact factor: 2.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.